Tradestie Institutional Equity Comparison Engine

EVMN vs SLN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVMN Overall Edge

EVMN Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Options & Structure while SLN counters with relative strength in Momentum & Technical. Fundamentally, EVMN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SLN at N/M Forward P/E and -10475.6% operating margin (+197.2% YoY). In options structure, EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro) against SLN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EVMN N/M vs SLN N/M Fwd P/E
Growth & Margin Winner EVMN
Op Margin 0.0% vs -10475.6% ยท YoY +0.0% vs +197.2%
Momentum & Technical Winner SLN
1Y -61.0% vs +186.1% ยท 52W Pos 8% vs 100%
Options & Structure Winner EVMN
SURGE (53rd %ile IV) vs UNCLASSIFIED (50th %ile IV)
EVMN US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap $315.5M
1M Return +37.33%
1Y Return -61.03%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 50.0 Fund 35.0 Flow 69.0 Mom 44.0
SLN NASDAQ
Silence Therapeutics Plc American Depository Share
Pharmaceutical Preparations
$19.80
-0.15% 1D
Market Cap $1.2B
1M Return +128.11%
1Y Return +186.13%
Forward P/E N/M
Unified AI Score
46.9 / 100 HOLD
Tech 24.0 Fund 34.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVMN -61.03% SLN +186.13% Spread: +247.16 pp (SLN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EVMN TTM Op. Margin: 0.0% SLN TTM Op. Margin: -10475.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVMN vs SLN. Trailing 12-month operating profitability (EVMN 0.0% vs SLN -10475.6%) and valuation multiples (EVMN N/M vs SLN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVMN (2) vs SLN (5)
Institutional Metric EVMN SLN Criterion Row Winner
Market Capitalization Scale $315.5M $1.2B Larger Scale SLN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +197.2% Higher Growth SLN
Operating Margin (TTM) Profitability 0.0% -10475.6% Higher Margin EVMN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -69.5% -90.4% Higher ROE EVMN
52-Week Range Position Momentum 8% ($5โ€“$33) 100% ($4โ€“$20) Stronger Trend SLN
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 118% Vol 1.91ฮฒ ยท 4% Vol Lower Realized Risk SLN
Unified Institutional Score Composite Signal 30.0 / 100 (SELL) 46.9 / 100 (HOLD) Higher Composite SLN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVMN vs SLN Buy Guide
EVMN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVMN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SLN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVMN nor SLN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.